# TBC1D2

## Overview
TBC1D2 is a gene that encodes the protein TBC1 domain family member 2, which is part of the TBC domain-containing RAB-specific GTPase-activating proteins (TBC/RABGAPs). This protein plays a pivotal role in cellular processes by regulating RAB proteins, which are involved in various intracellular trafficking pathways. TBC1 domain family member 2 is particularly significant in the regulation of autophagy and cell adhesion, processes essential for maintaining cellular homeostasis and tissue integrity. It interacts with small GTPases such as Rac1 and Rab7, influencing pathways that are critical in cancer metastasis, particularly in ovarian cancer and cutaneous melanoma. The dysregulation of TBC1D2 expression is associated with poor prognosis in these cancers, highlighting its potential as a therapeutic target (Tian2022TBC1D2; Tang2022A).

## Function
TBC1D2 is a member of the TBC domain-containing RAB-specific GTPase-activating proteins (TBC/RABGAPs), which play a crucial role in regulating RAB proteins involved in various cellular processes. In healthy human cells, TBC1D2 is involved in the regulation of autophagy, a process essential for cellular homeostasis. It coordinates Rac1 with Rab7 during autophagy, and its overexpression in normal human keratinocytes leads to the accumulation of enlarged autophagosomes, while its depletion significantly delays autophagic flux. This indicates that TBC1D2 is important for the regulation of autophagy, which is critical for the degradation and recycling of cellular components (Tian2022TBC1D2).

TBC1D2 also plays a role in regulating E-cadherin-mediated intercellular adhesion by modulating the Rac1-IQGAP1 complex. In normal ovarian epithelial cells, low levels of TBC1D2 stabilize the Rac1-IQGAP1 complex and E-cadherin-mediated intercellular adhesion, which is important for maintaining cell-cell adhesion and tissue integrity (Tian2022TBC1D2). These functions highlight TBC1D2's involvement in maintaining cellular structure and function through its regulatory roles in autophagy and cell adhesion.

## Clinical Significance
Alterations in the expression of the TBC1D2 gene have been implicated in several cancers, notably ovarian cancer (OC) and cutaneous melanoma (CM). In ovarian cancer, TBC1D2 is upregulated in cancerous tissues compared to normal tissues, and higher expression levels are associated with poorer prognosis. This gene promotes OC cell proliferation, migration, and invasion, contributing to tumor growth and metastasis by facilitating E-cadherin degradation, a process crucial for maintaining cell-cell adhesion (Tian2022TBC1D2). The degradation of E-cadherin is mediated through the disassembly of the Rac1-IQGAP1 complex, leading to increased cell invasion and metastasis (Tian2022TBC1D2). TBC1D2 expression is also linked to the infiltration of immune cells in the OC microenvironment, which may further promote cancer progression (Tian2022TBC1D2).

In cutaneous melanoma, elevated TBC1D2 expression is associated with an increased risk of death, suggesting its role as an oncogene in this context (Tang2022A). The gene's involvement in cancer prognosis highlights its potential as a therapeutic target. While specific mutations in TBC1D2 and their clinical significance in diseases other than cancer are not detailed, its dysregulation is clearly linked to cancer progression and metastasis.

## Interactions
TBC1D2 interacts with several proteins that play crucial roles in cellular processes related to cancer metastasis. It is known to bind with Rac1, a small GTPase involved in cell migration and invasion. This interaction leads to the disassembly of the Rac1-IQGAP1 complex, which is essential for maintaining cell-cell adhesion through E-cadherin stabilization. The disruption of this complex by TBC1D2 results in the degradation of E-cadherin, facilitating ovarian cancer cell invasion and metastasis (Tian2022TBC1D2).

TBC1D2 also interacts with Rab7, another small GTPase, although the specific functional outcomes of this interaction in the context of cancer are not detailed in the provided studies (Tian2022TBC1D2). The protein's role in modulating these interactions highlights its potential as a therapeutic target in ovarian cancer, as its overexpression is associated with poor prognosis and increased tumor metastasis (Tian2022TBC1D2).

These interactions underscore the importance of TBC1D2 in regulating key pathways involved in cell adhesion and migration, making it a significant factor in the progression of ovarian cancer.


## References


[1. (Tian2022TBC1D2) Jiming Tian, Xiaolei Liang, Dalin Wang, Jinglin Tian, Haiping Liang, Ting Lei, Zeyu Yan, Dan Wu, Xiaoli Liu, Shujuan Liu, and Yongxiu Yang. Tbc1d2 promotes ovarian cancer metastasis via inducing e-cadherin degradation. Frontiers in Oncology, April 2022. URL: http://dx.doi.org/10.3389/fonc.2022.766077, doi:10.3389/fonc.2022.766077. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.766077)

[2. (Tang2022A) Yifan Tang, Huicong Feng, Lupeng Zhang, Chiwen Qu, Jinlong Li, Xiangyu Deng, Suye Zhong, Jun Yang, Xiyun Deng, Xiaomin Zeng, Yiren Wang, and Xiaoning Peng. A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables. Scientific Reports, November 2022. URL: http://dx.doi.org/10.1038/s41598-022-23475-4, doi:10.1038/s41598-022-23475-4. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-23475-4)